Expanded US Approval Set To Take Janssen’s Darzalex Higher
Executive Summary
Janssen’s multiple myeloma therapy, Darzalex, has won an additional US approval for use earlier in the treatment paradigm, building momentum for a product that has already got off to a strong start.